Internet Archive Scholar

Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson's disease: Longitudinal data from the PPMI study [article]

Christos Koros, Athina Maria Simitsi, Anastasia Bougea, Nikolaos Papagiannakis, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Efthalia Angelopoulou, Ion Beratis, Efthymia Efthymiopoulou, Leonidas Stefanis, Maria Bozi (+5 others)
2021 medRxiv   pre-print

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (321.5 kB)
https://web.archive.org/web/20220517224130/https://www.medrxiv.org/content/medrxiv/early/2021/12/05/2021.12.04.21267290.full.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

The role of blood uric acid and more recently bilirubin as biomarkers in symptomatic motor PD has been increasingly established in the literature. Objective: Our present study assessed the role of serum uric acid and total bilirubin as putative biomarkers in a prodromal PD cohort followed longitudinally. Methods: Longitudinal 5-year serum uric acid and total bilirubin measurement data of 65 Prodromal PD patients (including REM Sleep Behavior disorder (RBD), N=39 and Hyposmia, N=26) with an
more » ... mal DATSCAN imaging were downloaded from the Parkinson's Progression Markers Initiative (PPMI) database. This cohort was compared with 423 de novo sporadic PD patients and 196 healthy controls enrolled in the same study. Results: After adjusting for age, sex and Body Mass Index (BMI), baseline and 5-year longitudinal serum uric acid levels were higher in the Prodromal cohort and RBD subgroup as compared to the motor PD cohort. This was also true for longitudinal measurements in the Hyposmic subgroup. In contrast, baseline and longitudinal serum total bilirubin did not differ between each prodromal group and the PD cohort. Conclusions: Our results are indicative of a role of serum uric acid (but probably not of total bilirubin) as a marker of neuroprotection, in a certain subgroup of premotor patients exhibiting exclusively non motor features (hyposmia or RBD). It is possible that an inherent antioxidant resistance of a subset of RBD or hyposmia patients with high serum uric acid level delayed or precluded the emergence of a motor PD phenotype as opposed to the PD cohort.
doi:10.1101/2021.12.04.21267290 fatcat:ilk5msu3rjbijkoqyix2stq6vq
Citation

Christos Koros, Athina Maria Simitsi, Anastasia Bougea, Nikolaos Papagiannakis, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Efthalia Angelopoulou, Ion Beratis, Efthymia Efthymiopoulou, Leonidas Stefanis, Maria Bozi, Sokratis G. Papageorgiou, Xenia Geronicola Trapali, Anastasios Bonakis, Maria Stamelou, Maria Stamelou. "Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson's disease: Longitudinal data from the PPMI study." medRxiv (2021)